Bill McBride
Impact in
-
- Radiopharmaceutical Chemistry and Applications
- Medical Imaging Techniques and Applications
- Monoclonal and Polyclonal Antibodies Research
-
- Synthetic Organic Chemistry Methods
Papers in
-
- Radiopharmaceutical Chemistry and Applications 10
- Monoclonal and Polyclonal Antibodies Research 6
- Medical Imaging Techniques and Applications 3
-
- Synthetic Organic Chemistry Methods 2
- Chemical Reaction Mechanisms 2
- Chemical Synthesis and Reactions 2
- Co-authors
- Michael E. Garst (6 shared papers)Ronald M. Baldwin (5 shared papers)David M. Goldenberg (5 shared papers)Roger T. Dean (2 shared papers)Shankar Vallabhajosula (2 shared papers)Brian R. Moyer (2 shared papers)John Lister‐James (2 shared papers)James G. Douglass (1 shared paper)
- Journals
- The Journal of Organic Chemistry (4 papers)Tetrahedron Letters (2 papers)Life Sciences (1 paper)Journal of Medicinal Chemistry (1 paper)Tetrahedron (1 paper)
- Partner nations
- United StatesNetherlandsIreland
In The Last Decade
Bill McBride
22 papers receiving 458 citations
Peers
Comparison fields: 5 of 65
- Radiology, Nuclear Medicine and Imaging 269
- Organic Chemistry 127
- Oncology 109
- Cellular and Molecular Neuroscience 45
- Pulmonary and Respiratory Medicine 70
Countries citing papers authored by Bill McBride
This map shows the geographic impact of Bill McBride's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bill McBride with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bill McBride more than expected).
Fields of papers citing papers by Bill McBride
This network shows the impact of papers produced by Bill McBride. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bill McBride. The network helps show where Bill McBride may publish in the future.
Co-authors
The 25 scholars most cited alongside Bill McBride, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Preclinical evaluation of technetium-99m-labeled somatostatin receptor-binding peptides. | 1996 | 80 |
| 2 | Improved iodine radiolabels for monoclonal antibody therapy. | 2003 | 59 |
| 3 | 1990 | 51 | |
| 4 | Pretargeting with bispecific anti-renal cell carcinoma x anti-DTPA(In) antibody in 3 RCC models. | 2005 | 40 |
| 5 | 1999 | 34 | |
| 6 | 1983 | 29 | |
| 7 | 1991 | 24 | |
| 8 | 1993 | 22 | |
| 9 | 1983 | 20 | |
| 10 | Pre-clinical evaluation of technetium-99m platelet receptor-binding peptide. | 1997 | 20 |
| 11 | Residualizing iodine markedly improved tumor targeting using bispecific antibody-based pretargeting. | 2005 | 19 |
| 12 | 1994 | 18 | |
| 13 | 1993 | 12 | |
| 14 | 1983 | 11 | |
| 15 | 1989 | 9 | |
| 16 | Technetium-99m-N1-(2-mercapto-2-methylpropyl)-N2-(2-propargylthio-2- methylpropyl)-1,2-benzenediamine (T691): preclinical studies of a potential new tracer of regional cerebral perfusion. | 1992 | 7 |
| 17 | 1984 | 6 | |
| 18 | 1987 | 5 | |
| 19 | Two-step targeting of RCC tumors in mice : Improved tumor uptake and retention with a bivalent chelate | 1998 | 5 |
| 20 | A new tri-Fab recombinant bispecific antibody (bsMAb) for pretargeting epithelial cancers: Studies with TF12 and 111In-labeled hapten-peptide (IMP 288) in ovarian cancer | 2010 | 3 |
About Bill McBride
Bill McBride is a scholar working on Radiology, Nuclear Medicine and Imaging, Organic Chemistry, Molecular Biology, Oncology and Cellular and Molecular Neuroscience, having authored 22 papers that have together received 477 indexed citations. Recurring topics across this work include Radiopharmaceutical Chemistry and Applications (10 papers), Monoclonal and Polyclonal Antibodies Research (6 papers), Medical Imaging Techniques and Applications (3 papers), Chemical Synthesis and Analysis (2 papers), Synthetic Organic Chemistry Methods (2 papers), Cancer, Hypoxia, and Metabolism (2 papers), Chemical Reaction Mechanisms (2 papers) and Chemical Synthesis and Reactions (2 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (269 citations), Organic Chemistry (127 citations), Oncology (109 citations), Cellular and Molecular Neuroscience (45 citations) and Pulmonary and Respiratory Medicine (70 citations). Bill McBride has collaborated with scholars based in United States, Netherlands and Ireland. Frequent co-authors include Michael E. Garst, Ronald M. Baldwin, David M. Goldenberg, Roger T. Dean, Shankar Vallabhajosula, Brian R. Moyer, John Lister‐James, James G. Douglass, M. Jules Mattes and Gary L. Griffiths. Their work appears in journals such as The Journal of Organic Chemistry, Tetrahedron Letters, Life Sciences, Journal of Medicinal Chemistry and Tetrahedron.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.